1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 1,n(6)-ethenoadenosine 3',5'-monophosphate in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (1,n(6)-ethenoadenosine 3',5'-monophosphate) | Trials (1,n(6)-ethenoadenosine 3',5'-monophosphate) | Recent Studies (post-2010) (1,n(6)-ethenoadenosine 3',5'-monophosphate) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 8 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deussen, A; Pexa, A | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1,n(6)-ethenoadenosine 3',5'-monophosphate
Article | Year |
---|---|
Modulation of ecto-5'-nucleotidase by phospholipids in human umbilical vein endothelial cells (HUVEC).
Topics: 5'-Nucleotidase; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Lysophosphatidylcholines; Molecular Structure; Phospholipids; Platelet Activating Factor; Sphingosine; Umbilical Veins | 2005 |